March 20, 2026

FDA Approves Chemoimmunotherapy Regimen for Hodgkin Lymphoma

Nivolumab (Opdivo) with doxorubicin, vinblastine, and dacarbazine (AVD) was approved today for adult and pediatric patients aged 12 years and older with previously untreated stage III or IV classical ...

The ASCO Post

March 18, 2026

HPV Vaccine Delays Persist in Teens

Missed opportunities for HPV vaccination before sexual debut remain common, with practice variation and timing influencing uptake

Conexiant

March 16, 2026

Sunscreen Costs Vary Up to 36-Fold

Economic analysis finds large differences in the annual cost of recommended sunscreen use depending on product price and clothing-based sun protection strategies

Conexiant

March 13, 2026

Deep-UV Raman Reveals mRNA Encapsulation in Lipid Nanoparticles 

Spectroscopic analysis reveals lipid–RNA interactions governing nanoparticle formulation efficiency 

The Analytical Scientist

March 04, 2026

The Gene Fixer

For five decades, Stuart Orkin has harnessed new genetic tools to transform care for blood disorders – helping make sickle cell and beta thalassemia curable.

Dana-Farber

March 04, 2026

Dana-Farber Researchers Join Global Cancer Grand Challenges Team Taking on the Dark Proteome

A global, interdisciplinary team of researchers including Dana-Farber’s Cathy Wu, MD, and William Freed-Pastor, MD, PhD, have been selected to receive a Cancer Grand Challenges award of up to $25m over five years to tackle the dark proteome challenge.

Dana-Farber

March 05, 2026

Calcium Strategy Following Thyroidectomy

Investigators compare routine prophylaxis vs postoperative parathyroid hormone-guided supplementation.

Conexiant

March 03, 2026

HPV Uptake Grows Over Time

Clinical trial finds that, while multicomponent strategy did not significantly boost HPV vaccination at fixed time points, initiation rates improved steadily over time

Conexiant

February 26, 2026

How the Outlook on Fertility Preservation for Patients With Cancer Is Improving

Each year in the United States, about 90,000 adolescents and young adults (AYAs), ages 15 to 39, are diagnosed with cancer,1 and they are immediately faced with myriad challenges and disruptions in th...

The ASCO Post

February 11, 2026

Making Breakthroughs in ALL From Youth to Adulthood

When Ann Carroll was diagnosed with cancer at age 28, her dream to get married and have a baby felt out of reach. Now, seven years later and cancer-free, she is living that dream with her husband and their 7-month-old son, Teddy.  

Dana-Farber